NCT05514210Completed
Feasibility and Effectiveness of a Real-time Heart Team Approach in Complex CAD
Feasibility and Effectiveness of a Real-time Heart Team Approach in Complex Coronary Artery Disease
Source: ClinicalTrials.gov · Last updated 30 Jul 2025
Brief summary (registry, in English)
This study is aimed to evaluate the clinical outcomes, efficiency and feasibility of the real-time heart team approach and the conventional heart team approach.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 490 (actual)
- First submitted
- 22 Aug 2022
- Start date
- 15 Sept 2023
- Primary completion date
- 21 May 2025
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Diseases
- Coronary artery disease
- NCT number
- NCT05514210
What you commit to
- Study type: Interventional
- Participants enrolled: 490
- From 15 Sept 2023 to the primary completion date, 21 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous history of PCI or CABG;
Other illness
- Patients with severe heart valvular disease, major vascular disease, and giant ventricular aneurysm require surgical treatment;
- Combined with AF or severe arrhythmia;
Age
- Less than 18 years of age;
Other
- Admitted for AMI, ECG and biomarker detection indicated acute stage;
- Other patients admitted to hospital due to emergency circumstances who are not suitable to wait for elective revascularization;
- Rejection or exclusion of a revascularization mode (PCI or CABG);
- Refuse to participate in the study.
Who the study is looking for
- Significant stenosis in the left main or left main equivalent with or without stenosis in one of the other vessels\[Significant stenosis is defined as: 1) a diameter stenosis of at least 50% reduction in luminal diameter by visual assessment or 2) any total occlusion (no age limitation and no exclusion of unfavorable anatomic features); Left main equivalent disease is defined as significant stenosis of the ostium of the left anterior descending and the ostium of the left circumflex.\]
- At least 1 significant stenosis (≥ 70% obstruction) in all 3 major epicardial territories supplying viable myocardium;
- Other conditions that the interventional cardiologist considers necessary to discuss with cardiac surgeons due to technical and risk considerations.
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| China National Center for Cardiovascular Diseases Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
Related publications
- Real-Time Heart Team for Revascularization in Complex Coronary Artery Disease: The EHEART Randomized Trial.J Am Coll Cardiol · 2026 · PMID 41778947
This page is information, not medical advice. Discuss any trial with your doctor.